Although the main characteristic of chronic obstructive pulmonary disease (COPD) is
relentlessly worsening airflow limitation, many patients show some degree of reversibility …

5, 290, 815 A 3/1994 Johnson et al. 5, 435, 301 A 7/1995 Herold et al. 5, 507, 281 A 4/1996
Kuhnel et al. 5, 569, 447 A 10/1996 Lee et al. 5, 575, 280 A 11/1996 Gupte et al. 5, 610, 163 …

Abstract Die Gruppe der β2‐Sympathomimetika spielt trotz kontroverser Diskussionen über
die Sicherheit und Wirksamkeit eine wichtige Rolle in der Therapie der obstruktiven …

For over 50 years, asthma has been thought of, and treated as a disease of the smooth
muscle brought about by persistent inflammation in the airways. However, even when an …

The review considers and evaluates the methodology for the design of antiasthmatic
bronchodilators, selective stimulants of β 2-adrenergic receptors in bronchi (β 2-agonists) …

In this chapter the various therapies for the chronic maintenance and acute exacerbations of
asthmatic symptoms are explored by discussing (1) their mechanisms of drug action,(2) their …

The goal of asthma therapy is to reduce symptoms to the extent that patients can lead active,
unlimited lives and to minimize concern about exacerbations. Unfortunately, despite …

The present disclosure relates to pharmaceutical composi tions for inhalation comprising
aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admix ture …

Provided is a powder inhaler comprising a powder inhalant comprising 3 (R)-(2-hydroxy-2, 2-
dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo [2.2. 2] octane wherein an anion …

Lung diseases have been observed to be one of the devastating reasons of morbidity and
death globally. However, a continuous effort is being done from last many years to …